Adial Pharmaceuticals's total assets for Q1 2025 were $3.45M, a decrease of -31.58% from the previous quarter. ADIL total liabilities were $1.32M for the fiscal quarter, a 35.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.